Janssen and Arrowhead strike RNAi deal

05-10-2018

Janssen and Arrowhead strike RNAi deal

cecilie_arcurs / iStockphoto.com

Janssen, a subsidiary of Johnson & Johnson, has entered into a licence and collaboration agreement with drug maker Arrowhead Pharmaceuticals.


Janssen, Johnson & Johnson, J&J, Arrowhead Pharmaceuticals, licence, collaboration, RNAi therapeutics

LSIPR